TREATMENT OF EARLY STAGES OF HEART FAILURE

We performed a complex study of central, cardiac and peripheral regional hemodynamics (PRH), neurohumoral activity, tolerance to dosed physical stress, as wells life quality evaluation and comparative efficacy of long-term (12 months) sole7 treatment with enalapril, atenolol, nitrosorbid and verapam...

Full description

Saved in:
Bibliographic Details
Main Author: V. I. Vishnevsky
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2001-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2160
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850040989287186432
author V. I. Vishnevsky
author_facet V. I. Vishnevsky
author_sort V. I. Vishnevsky
collection DOAJ
description We performed a complex study of central, cardiac and peripheral regional hemodynamics (PRH), neurohumoral activity, tolerance to dosed physical stress, as wells life quality evaluation and comparative efficacy of long-term (12 months) sole7 treatment with enalapril, atenolol, nitrosorbid and verapamil in 108 patients with a history of MI and mild heart failure, with a sinus rhythm at the baseline. We have shown enalapril to influence beneficially LV systolic and diastolic function, central hemodynamics, thromboxan-prostacyclin misbalance, enhanced PRH, decreased plasma norepinephrin and aldosterone activities by the end of the 1st week. Atenolol increased LV systolic and diastolic function by the end of the 2-3th month of treatment, in a stable manner decreasing HR, norepinephrin concentration, increased tolerance to dosed physical stress and enhanced PRH moderately. Nitrosorbid influenced central and cardiac hemodynamics in a moderate way, had no effect on neurohumoral activity, LV diastolic function; the studied values by the end of the 3-4th month were comparable with those at baseline. Verapamil had no influence on LV systolic and diastolic function, enhanced PRH, mostly in the arterial part of the vasculature, increased plasma aldosterone activity. Enalapril and atenolol are the drugs of choice in treating mild heart failure in patients with a history of MI as they exert beneficial effect on most of the pathogenetic aspects of heart failure and improve life quality.
format Article
id doaj-art-9937b7d57d6d4e1a84f8e8f6a1d9d5a2
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2001-02-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-9937b7d57d6d4e1a84f8e8f6a1d9d5a22025-08-20T02:55:54Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202001-02-0101471912TREATMENT OF EARLY STAGES OF HEART FAILUREV. I. Vishnevsky0Курский государственный медицинский университетWe performed a complex study of central, cardiac and peripheral regional hemodynamics (PRH), neurohumoral activity, tolerance to dosed physical stress, as wells life quality evaluation and comparative efficacy of long-term (12 months) sole7 treatment with enalapril, atenolol, nitrosorbid and verapamil in 108 patients with a history of MI and mild heart failure, with a sinus rhythm at the baseline. We have shown enalapril to influence beneficially LV systolic and diastolic function, central hemodynamics, thromboxan-prostacyclin misbalance, enhanced PRH, decreased plasma norepinephrin and aldosterone activities by the end of the 1st week. Atenolol increased LV systolic and diastolic function by the end of the 2-3th month of treatment, in a stable manner decreasing HR, norepinephrin concentration, increased tolerance to dosed physical stress and enhanced PRH moderately. Nitrosorbid influenced central and cardiac hemodynamics in a moderate way, had no effect on neurohumoral activity, LV diastolic function; the studied values by the end of the 3-4th month were comparable with those at baseline. Verapamil had no influence on LV systolic and diastolic function, enhanced PRH, mostly in the arterial part of the vasculature, increased plasma aldosterone activity. Enalapril and atenolol are the drugs of choice in treating mild heart failure in patients with a history of MI as they exert beneficial effect on most of the pathogenetic aspects of heart failure and improve life quality.https://russjcardiol.elpub.ru/jour/article/view/2160chronic heart failuretreatment with d-blockersace inhibitorscalcium antagonistscardiac hemodynamicshumoral regulation
spellingShingle V. I. Vishnevsky
TREATMENT OF EARLY STAGES OF HEART FAILURE
Российский кардиологический журнал
chronic heart failure
treatment with d-blockers
ace inhibitors
calcium antagonists
cardiac hemodynamics
humoral regulation
title TREATMENT OF EARLY STAGES OF HEART FAILURE
title_full TREATMENT OF EARLY STAGES OF HEART FAILURE
title_fullStr TREATMENT OF EARLY STAGES OF HEART FAILURE
title_full_unstemmed TREATMENT OF EARLY STAGES OF HEART FAILURE
title_short TREATMENT OF EARLY STAGES OF HEART FAILURE
title_sort treatment of early stages of heart failure
topic chronic heart failure
treatment with d-blockers
ace inhibitors
calcium antagonists
cardiac hemodynamics
humoral regulation
url https://russjcardiol.elpub.ru/jour/article/view/2160
work_keys_str_mv AT vivishnevsky treatmentofearlystagesofheartfailure